TLR3 activation enhances antitumor effects of sorafenib in hepatocellular carcinoma by activating NK cell functions through ERK and NF-κB pathways

Qiangbo Zhang(Qilu Hospital of Shandong University), Enyu Liu(Yan'an University)
Scientific Reports
November 2, 2024
Cited by 2


Related Papers